Brett A. Grimaud - 20 Nov 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, GEN COUNSEL AND SECRETARY
Signature
/s/ Brett A. Grimaud
Issuer symbol
TBPH
Transactions as of
20 Nov 2023
Net transactions value
-$76,354
Form type
4
Filing time
22 Nov 2023, 18:11:55 UTC
Previous filing
22 Aug 2023
Next filing
22 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Tax liability $76,354 -7,363 -2.6% $10.37 278,279 20 Nov 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
F2 Includes 345 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2023.